[HTML][HTML] Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity

W Bobela, S Nazeeruddin, G Knott, P Aebischer… - Molecular …, 2017 - Springer
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

Modulating the catalytic activity of AMPK has neuroprotective effects against [alpha]-synuclein toxicity

W Bobela, S Nazeeruddin, G Knott… - Molecular …, 2017 - go.gale.com
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

[HTML][HTML] Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity

W Bobela, S Nazeeruddin… - Molecular …, 2017 - molecularneurodegeneration …
Metabolic perturbations and slower renewal of cellular components associated with aging
increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical cellular …

[HTML][HTML] Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity

W Bobela, S Nazeeruddin, G Knott… - Molecular …, 2017 - ncbi.nlm.nih.gov
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity.

W Bobela, S Nazeeruddin, G Knott… - Molecular …, 2017 - search.ebscohost.com
Background: Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity.

W Bobela, S Nazeeruddin, G Knott… - Molecular …, 2017 - europepmc.org
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity

W Bobela, S Nazeeruddin, G Knott, P Aebischer… - Molecular …, 2017 - infona.pl
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity

W Bobela, S Nazeeruddin, G Knott… - Molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity.

W Bobela, S Nazeeruddin, G Knott, P Aebischer… - Molecular …, 2017 - sonar.ch
METHODS Here, we overexpress various genetic variants of the catalytic AMPKα subunit to
determine how AMPK activity affects the survival and function of neurons overexpressing …

Modulating the catalytic activity of AMPK has neuroprotective effects against Alpha-synuclein toxicity

W Bobela, S Nazeeruddin, G Knott… - Molecular …, 2017 - search.proquest.com
Background Metabolic perturbations and slower renewal of cellular components associated
with aging increase the risk of Parkinson's disease (PD). Declining activity of AMPK, a critical …